Travelers to high-risk areas for infectious diseases are recommended to receive vaccinations tailored to the specific endemic risks of their destination. Core vaccines commonly advised include hepatitis A and B, typhoid, yellow fever, meningococcal, rabies, Japanese encephalitis, and cholera vaccines where appropriate. Hepatitis B vaccination is particularly important for travelers with potential exposure to blood or bodily fluids and can be administered using an accelerated schedule to ensure protection before travel commences NICE NG218 Keystone 2005. Cholera vaccination is recommended for travelers to areas with active cholera transmission, especially where access to safe water and sanitation is limited Gabutti et al. 2020. Yellow fever vaccination is mandatory for entry into certain countries and is critical for protection against this potentially fatal disease NICE NG218. Meningococcal vaccination is advised for travelers to the meningitis belt in sub-Saharan Africa or during outbreaks NICE NG218. Rabies vaccination should be considered for travelers at high risk of animal bites or prolonged exposure in endemic regions NICE NG218. Japanese encephalitis vaccine is recommended for travelers spending extended periods in rural Asia or during transmission seasons NICE NG218. The choice and timing of vaccines should be individualized based on travel itinerary, duration, activities, and underlying health status, with accelerated or combined schedules used when necessary to ensure timely protection NICE NG218 Keystone 2005. This integrated approach aligns UK vaccination guidelines with current evidence on vaccine efficacy and disease risk in travelers, ensuring comprehensive prevention strategies for high-risk infectious diseases NICE NG218 Gabutti et al. 2020.
What vaccinations are recommended for travellers to high-risk areas for infectious diseases?
Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.
Posted: 16 August 2025Updated: 16 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX